Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability

SPECIAL REPORT

HIV / AIDS

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Bacterial Infections

Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial

Clin Microbiol Infect.

Rob F, Klubalová B, Nyčová E, Hercogová J, Unemo M

doi: 10.1016/j.cmi.2019.08.004.

Bacterial Infections

Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review

Lancet Infect Dis.

O'Brien KS, Emerson P, Hooper PJ, Reingold AL, Dennis EG, Keenan JD, Lietman TM, Oldenburg CE

doi: 10.1016/S1473-

Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection

Am J Gastroenterol.

Chen MJ, Chen CC, Chen YN, Chen CC, Fang YJ, Lin JT, Wu MS, Liou JM, Taiwan Gastrointestinal Disease and Helicobacter Consortium

doi: 10.1038/s41395-018-0217-2.

Bacterial Infections

Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study

Clin Infect Dis.

Klausner JD, Bristow CC, Soge OO, Shahkolahi A, Waymer T, Bolan RK, Philip SS, Asbel LE, Taylor SN, Mena LA, Goldstein DA, Powell JA, Wierzbicki MR, Morris SR

doi: 10.1093/cid/ciaa596.

Viral Infections, Non-HIV

The vaginal microbiota and its association with Human Papillomavirus, Chlamydia trachomatis, Neisseria gonorrhea and Mycoplasma genitalium infections: a systematic review and meta-analysis

Clin Microbiol Infect.

Tamarelle J, Thiébaut ACM, de Barbeyrac B, Bébéar C, Ravel J, Delarocque-Astagneau E

doi: 10.1016/j.cmi.2018.04.019.

HIV / AIDS

HIV-2: A summary of present standard of care and treatment options for HIV-2 infected individuals living in Western Europe

Clin Infect Dis.

Berzow D, Descamps D, Obermeier M, Charpentier C, Kaiser R, Guertler L, Eberle J, Wensing A, Sierra S, Ruelle J, Gomes P, Mansinho K, Taylor N, Jensen B, Döring M, Stürmer M, Rockstroh J, Camacho R

doi: 10.1093/cid/ciaa275.

Drug Resistance

Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study

Antimicrob Resist Infect Control.

Birgand G, Mutters NT, Ahmad R, Tacconelli E, Lucet JC, Holmes A, Percept-R Study Group.

doi: 10.1186/s13756-020-0695-z.

Viral Infections, Non-HIV

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study

Clin Infect Dis.

Artenie AA, Cunningham EB, Dore GJ, Conway B, Dalgard O, Powis J, Bruggmann P, Hellard M, Cooper C, Read P, Feld JJ, Hajarizadeh B, Amin J, Lacombe K, Stedman C, Litwin AH, Marks P, Matthews GV, Quiene S, Erratt A, Bruneau J, Grebely J

doi: 10.1093/cid/ciz633.

Related content

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial

Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review

Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection

Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study

The vaginal microbiota and its association with Human Papillomavirus, Chlamydia trachomatis, Neisseria gonorrhea and Mycoplasma genitalium infections: a systematic review and meta-analysis

HIV-2: A summary of present standard of care and treatment options for HIV-2 infected individuals living in Western Europe

Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study